Purpose: Little is known about the molecular epidemiology of Staphylococcus aureus in 26 Chinese neonatal intensive care units (NICUs). We describe the molecular epidemiology of S. 27 aureus isolated from neonates on admission to Beijing Children's Hospital. 28 29 Methods: From May 2015-March 2016, nasal swabs were obtained on admission from 536 30 neonates. Cultures were also obtained from body sites with suspected infections. S. aureus 31 isolates were characterized by staphylococcal chromosomal cassette (SCCmec) type, 32 staphylococcal protein A (spa) type, multilocus sequence type (MLST), sasX gene, antimicrobial 33 susceptibility and cytotoxicity. Logistic regression assessed risk factors for colonization. 34 35
47
colonization were identified. These results suggest that screening infants for S. aureus upon 48 admission and targeting decolonization of high-risk infants and/or those colonized with high-risk 49 clones could be useful to prevent transmission.
INTRODUCTION
6 100 diagnoses of suspected infections as described in the NICU admission notes, were also 101 abstracted. Infants showing suggestive clinical symptoms were considered infected if S. aureus was isolated 113 from either a normally sterile site (eg, blood) or cultures obtained for clinical purposes (eg, skin 114 or eyes). The Clinical Microbiology Laboratory at BCH processed both surveillance and clinical 115 specimens. S. aureus was identified based on colony morphology and the coagulase test 116 (Saibaisheng, Beijing, China) . PCR was used to detect the mecA gene. [9] Isolates with zone 117 sizes less than 21 mm for cefoxitin discs (Sigma, USA), according to the criteria of Clinical and 118 Laboratory Standards Institute (CLSI), [10] and which were also mecA gene positive were 119 considered MRSA. All S. aureus isolates were stored at -20° C. To perform molecular studies, isolates were cultured by the research team on blood agar and 123 incubated overnight at 37°C. DNA was extracted and used to perform staphylococcal cassette Antimicrobial susceptibility was determined by the agar dilution method, in accordance with the 149 CLSI. [10] MRSA and MSSA isolates were tested for susceptibility to penicillin, oxacillin, 150 gentamicin, ceftriaxone, rifampin, sulfamethoxazole-trimethoprim (TMP-SMX), erythromycin, 151 mupirocin, and levofloxacin. MRSA was also tested for susceptibility to vancomycin, linezolid, 152 fusidic acid, and tigecycline. S. aureus ATCC 29213 was used as the quality control. associated with either S. aureus colonization, while antibiotic use in the week prior to admission 198 was protective. An additional adjusted logistic regression model assessing interaction between 199 birthweight quartiles and neonate age was assessed, but the interaction term was not significant 200 (p=0.09).
202
In multinomial logistic regression, female sex (p=0.02), vaginal delivery (p<0.0001), and age 7-203 28 days (p<0.0001) remained significant risk factors for MSSA colonization, while female sex 204 (p=0.03) and age 7-28 days (p=0.001) remained significant risk factors for MRSA colonization. (p=0.85) as shown in Figure 2A . The cytotoxicity of the 96 colonizing S. aureus isolates 257 (median: 85%, IQR [73-87%]) was less than that of the 23 infectious isolates (median: 88%, IQR
258
[82-88%], p=0.0008) ( Figure 2B In conclusion, the nasal colonization rate of S. aureus in neonates was high in the NICU of BCH.
389
Female sex, age 7-28 days, birthweight and vaginal delivery were risk factors for colonization.
390
While MSSA more frequently colonized neonates, MRSA more frequently infected neonates.
391
Most S. aureus strains were community-associated, reflective of NICU admission patterns.
392
Isolates associated with clinical infection exhibited higher cytotoxicity than colonizing isolates.
393
Our findings suggest that active surveillance of neonates for S. aureus should be considered as 394 part of strategies to detect importation and prevent transmission of both MRSA and MSSA 395 within the NICU. 
